KFDA approves 26 Stillen generics

Published: 2009-02-05 06:58:00

Updated: 2009-02-05 06:58:00

Dong-A Pharm’s Stillen, is unlikely to become a cash cow product as a total of 26 drug manufacturers, including Chong Kung Dang Pharmaceutical, Dongwha Pharm and Kwagdong, obtained a nod for Stillen generics from the Korea Food and Drug Administration.

CKDP already received the market authoriz...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK